Pancreatic Cancer: Pathogenesis and Clinical Studies.

MedComm (2020) · 2025 · PMC11965705 · PMID 40182139

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the triple combination of GVAX, nivolumab, and urelumab exhibited the most favorable survival outcomes, the differences did not reach statistical significance, likely due to the limited sample size [ 367 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.